Earnings Growth Stocks in Health Care
Companies with year-over-year net income growth exceeding 10%, showing expanding profitability from already profitable operations.
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
36 Companies Meeting Criteria
| # | Company | Earnings Growth | Net Income | Profit Margin |
|---|---|---|---|---|
| 1 | TALKTalkspace, Inc. | 578.8% | $1M | 4.2% |
| 2 | TMDXTransMedics Group, Inc. | 436.6% | $35M | 8.0% |
| 3 | GMEDGlobus Medical | 422.3% | - | - |
| 4 | STESteris | 253.4% | $615M | 11.3% |
| 5 | PACSPACS Group, Inc. | 243.5% | $56M | 1.4% |
| 6 | SOLVSolventum | 224.8% | $1.5B | 18.1% |
| 7 | VCYTVeracyte, Inc. | 174.9% | $24M | 5.4% |
| 8 | INSPInspire Medical Systems, Inc. | 171.8% | $54M | 6.7% |
| 9 | CAHCardinal Health | 83.2% | $1.6B | 0.7% |
| 10 | SHCSotera Health | 75.6% | $44M | 4.0% |
| 11 | CICigna | 73.5% | $6.5B | 2.4% |
| 12 | PRVAPrivia Health Group, Inc. | 59.3% | $14M | - |
| 13 | BSXBoston Scientific | 56.7% | $2.8B | 14.4% |
| 14 | DXCMDexcom | 45.1% | $721M | 16.0% |
| 15 | MCKMcKesson Corporation | 44.5% | $3.3B | 0.9% |
| 16 | RMDResMed | 37.2% | $1.4B | 27.2% |
| 17 | RSMDFResMed | 37.2% | $1.4B | 27.2% |
| 18 | PNTGPennant Group, Inc. | 31.1% | $23M | 3.2% |
| 19 | LMATLeMaitre Vascular | 31.1% | $44M | 20.0% |
| 20 | UHSUniversal Health Services | 30.4% | $1.4B | 8.1% |
| 21 | ADUSAddus HomeCare Corp. | 30.3% | $74M | 6.4% |
| 22 | USPHU.S. Physical Therapy, Inc. | 26.0% | $31M | 4.7% |
| 23 | EHCEncompass Health | 24.2% | - | - |
| 24 | ISRGIntuitive Surgical | 23.0% | $2.7B | 28.6% |
| 25 | CDRECadre Holdings, Inc. | 22.2% | $36M | 6.4% |
| 26 | EMBCEmbecta Corp. | 21.8% | $95M | 8.8% |
| 27 | IDXXIdexx Laboratories | 19.3% | $1.0B | 24.6% |
| 28 | HCAHCA Healthcare | 17.8% | $6.3B | 8.5% |
| 29 | NHCNational Healthcare, Corp. | 17.7% | $139M | 12.9% |
| 30 | LHLabcorp | 17.5% | $855M | 6.2% |
| 31 | IRMDIRADIMED CORP | 16.9% | $13M | 24.1% |
| 32 | ENSGEnsign Group | 15.4% | $298M | 7.0% |
| 33 | MDXGMIMEDX GROUP, INC. | 14.5% | $42M | 12.2% |
| 34 | DGXQuest Diagnostics | 13.9% | $969M | 8.9% |
| 35 | TCMDTACTILE SYSTEMS TECHNOLOGY INC | 12.5% | $17M | 5.8% |
| 36 | MEDPMedpace | 11.6% | $433M | 18.4% |
Understanding Earnings Growth
Earnings growth measures the increase in a company's net income (bottom line) from one year to the next. Unlike revenue growth, earnings growth captures improvements in operational efficiency, cost management, and pricing power. This screener only includes companies profitable in both years, ensuring the growth rate reflects genuine business improvement rather than a turnaround from losses.
YoY Net Income Growth > 10%, Profitable Both Years
Results are based on SEC EDGAR filings. Companies with missing, unreliable, or extreme outlier values are excluded from screening.
Related Rankings
See the top companies ranked by these related metrics